Teva Hears No Again In Risperdal Spat
Shedding some light on its earlier decision, the U.S. District Court for the District of Columbia has reiterated its decision to deny Teva Pharmaceuticals Inc.'s ongoing bid for marketing exclusivity for...To view the full article, register now.
Already a subscriber? Click here to view full article